Abstract The National Centre for Oncological Hadrontherapy (CNAO, sited in Pavia, Italy) completed at the end of 2013 the clinical trial phase achieving the CE label from the notified …
C Richter, G Pausch, S Barczyk, M Priegnitz… - Radiotherapy and …, 2016 - Elsevier
Background and purpose To improve precision of particle therapy, in vivo range verification is highly desirable. Methods based on prompt gamma rays emitted during treatment seem …
Purpose To determine the accuracy of particle range prediction for proton and heavier ion radiation therapy based on dual-energy computed tomography (DECT) in a realistic …
Background and purpose To reduce range uncertainty in particle therapy, an accurate computation of stopping-power ratios (SPRs) based on computed tomography (CT) is …
M Fischetti, G Baroni, G Battistoni, G Bisogni… - Scientific Reports, 2020 - nature.com
The high dose conformity and healthy tissue sparing achievable in Particle Therapy when using C ions calls for safety factors in treatment planning, to prevent the tumor under-dosage …
T Pfeiler, C Bäumer, E Engwall, D Geismar… - … für Medizinische Physik, 2018 - Elsevier
Respiratory induced organ motion poses a major challenge for high-precision radiotherapy such as pencil beam scanning proton therapy (PBS). In order to employ PBS for target …
Background and purpose A prompt-gamma imaging (PGI) slit-camera was recently applied successfully in clinical proton treatments using pencil beam scanning (PBS) and double …
Purpose Range prediction in particle therapy is associated with an uncertainty originating from calculating the stopping-power ratio (SPR) based on x-ray computed tomography (CT) …
Background and Purpose Proton treatment planning relies on an accurate determination of stopping‐power ratio (SPR) from x‐ray computed tomography (CT). A refinement of the …